• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国武汉严重 COVID-19 感染患者的流行病学特征:一项回顾性观察研究的证据。

Epidemiological characteristics of patients with severe COVID-19 infection in Wuhan, China: evidence from a retrospective observational study.

机构信息

Department of Epidemiology and Biostatistics, School of Health Sciences, Wuhan University, Wuhan, China.

School of Public Health and Management, Hubei University of Medicine, Shiyan, China.

出版信息

Int J Epidemiol. 2021 Jan 23;49(6):1940-1950. doi: 10.1093/ije/dyaa180.

DOI:10.1093/ije/dyaa180
PMID:33150437
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7665537/
Abstract

BACKGROUND

The new coronavirus (COVID-19) rapidly resulted in a pandemic. We report the characteristics of patients with severe or critical severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in Wuhan city, China, and the risk factors related to infection severity and death.

METHODS

We extracted the demographic and clinical data of 7283 patients with severe COVID-19 infection from designated Wuhan hospitals as of 25 February 2020. Factors associated with COVID-19 critical illness and mortality were analysed using logistic- and Cox-regression analyses.

RESULTS

We studied 6269 patients with severe COVID-19 illness and 1014 critically ill patients. The median (IQR) age was 64 (53-71) years; 51.2% were male, 38.9% were retirees and 7.4% had self-reported histories of chronic disease. Up to the end of the study, 1180 patients (16.2%) recovered and were discharged, 649 (8.9%) died and the remainder were still receiving treatment. The number of daily confirmed critical cases peaked between 23 January and 1 February 2020. Patients with advanced age [odds ratio (OR), 1.03; 95% confidence intervals (CIs), 1.03-1.04], male sex (OR, 1.57; 95% CI, 1.33-1.86) and pre-existing diabetes (OR, 2.11), hypertension (OR, 2.72), cardiovascular disease (OR, 2.15) or respiratory disease (OR, 3.50) were more likely to be critically ill. Compared with those who recovered and were discharged, patients who died were older [hazard ratio (HR), 1.04; 95% CI, 1.03-1.05], more likely to be male (HR, 1.74; 95% CI, 1.44-2.11) and more likely to have hypertension (HR, 5.58), cardiovascular disease (HR, 1.83) or diabetes (HR, 1.67).

CONCLUSION

Advanced age, male sex and a history of chronic disease were associated with COVID-19 critical illness and death. Identifying these risk factors could help in the clinical monitoring of susceptible populations.

摘要

背景

新型冠状病毒(COVID-19)迅速引发了大流行。我们报告了中国武汉市严重或危重严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)感染患者的特征,以及与感染严重程度和死亡相关的危险因素。

方法

截至 2020 年 2 月 25 日,我们从指定的武汉医院提取了 7283 例严重 COVID-19 感染患者的人口统计学和临床数据。使用逻辑回归和 Cox 回归分析来分析与 COVID-19 重症和死亡相关的因素。

结果

我们研究了 6269 例严重 COVID-19 疾病患者和 1014 例危重症患者。中位(IQR)年龄为 64(53-71)岁;51.2%为男性,38.9%为退休人员,7.4%有自我报告的慢性病史。截至研究结束时,1180 例(16.2%)患者康复出院,649 例(8.9%)死亡,其余仍在接受治疗。每日确诊重症病例数在 2020 年 1 月 23 日至 2 月 1 日期间达到峰值。年龄较大的患者[比值比(OR),1.03;95%置信区间(CI),1.03-1.04]、男性(OR,1.57;95%CI,1.33-1.86)和患有糖尿病(OR,2.11)、高血压(OR,2.72)、心血管疾病(OR,2.15)或呼吸系统疾病(OR,3.50)的患者更容易出现重症。与康复出院的患者相比,死亡患者年龄更大[风险比(HR),1.04;95%CI,1.03-1.05],更可能是男性(HR,1.74;95%CI,1.44-2.11),并且更可能患有高血压(HR,5.58)、心血管疾病(HR,1.83)或糖尿病(HR,1.67)。

结论

年龄较大、男性和慢性病史与 COVID-19 重症和死亡相关。识别这些危险因素有助于对易感人群进行临床监测。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db05/7825939/9be029ddaa73/dyaa180f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db05/7825939/44c1c114a944/dyaa180f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db05/7825939/9be029ddaa73/dyaa180f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db05/7825939/44c1c114a944/dyaa180f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db05/7825939/9be029ddaa73/dyaa180f2.jpg

相似文献

1
Epidemiological characteristics of patients with severe COVID-19 infection in Wuhan, China: evidence from a retrospective observational study.中国武汉严重 COVID-19 感染患者的流行病学特征:一项回顾性观察研究的证据。
Int J Epidemiol. 2021 Jan 23;49(6):1940-1950. doi: 10.1093/ije/dyaa180.
2
Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China.中国武汉 2019 年冠状病毒病肺炎患者急性呼吸窘迫综合征和死亡的相关危险因素。
JAMA Intern Med. 2020 Jul 1;180(7):934-943. doi: 10.1001/jamainternmed.2020.0994.
3
Clinical Characteristics and Risk Factors for Mortality of COVID-19 Patients With Diabetes in Wuhan, China: A Two-Center, Retrospective Study.中国武汉 COVID-19 合并糖尿病患者的临床特征和死亡危险因素:一项两中心回顾性研究。
Diabetes Care. 2020 Jul;43(7):1382-1391. doi: 10.2337/dc20-0598. Epub 2020 May 14.
4
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.《武汉 2019 年新型冠状病毒感染的肺炎 138 例住院患者临床特征分析》
JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585.
5
Characteristics and outcomes of patients hospitalized for COVID-19 in France: The Critical COVID-19 France (CCF) study.法国 COVID-19 住院患者的特征和结局:Critical COVID-19 France(CCF)研究。
Arch Cardiovasc Dis. 2021 May;114(5):352-363. doi: 10.1016/j.acvd.2021.01.003. Epub 2021 Mar 2.
6
Risk Factors for Poor Outcomes of Diabetes Patients With COVID-19: A Single-Center, Retrospective Study in Early Outbreak in China.中国新冠肺炎疫情早期单中心回顾性研究:糖尿病合并 COVID-19 患者不良预后的危险因素。
Front Endocrinol (Lausanne). 2020 Sep 24;11:571037. doi: 10.3389/fendo.2020.571037. eCollection 2020.
7
Identification of risk factors for in-hospital death of COVID - 19 pneumonia -- lessions from the early outbreak.鉴定 COVID-19 肺炎院内死亡的风险因素——来自早期爆发的教训。
BMC Infect Dis. 2021 Jan 25;21(1):113. doi: 10.1186/s12879-021-05814-4.
8
Clinical Characteristics of Patients with Severe Pneumonia Caused by the SARS-CoV-2 in Wuhan, China.中国武汉严重肺炎患者的临床特征。
Respiration. 2020;99(8):649-657. doi: 10.1159/000507940. Epub 2020 Aug 25.
9
Morbidity and mortality outcomes of COVID-19 patients with and without hypertension in Lagos, Nigeria: a retrospective cohort study.尼日利亚拉各斯 COVID-19 患者合并与不合并高血压的发病率和死亡率结局:一项回顾性队列研究。
Glob Health Res Policy. 2021 Jul 29;6(1):26. doi: 10.1186/s41256-021-00210-6.
10
Clinical Characteristics and Prognosis of 244 Cardiovascular Patients Suffering From Coronavirus Disease in Wuhan, China.中国武汉 244 例心血管病患者感染冠状病毒疾病的临床特征和预后。
J Am Heart Assoc. 2020 Oct 20;9(19):e016796. doi: 10.1161/JAHA.120.016796. Epub 2020 Aug 14.

引用本文的文献

1
Reporting of health equity considerations in equity-relevant observational studies: Protocol for a systematic assessment.在与公平性相关的观察性研究中报告健康公平性考量因素:一项系统评估方案
F1000Res. 2022 Jun 6;11:615. doi: 10.12688/f1000research.122185.1. eCollection 2022.
2
Polymorphisms Influence the Expression of the Fas and FasL Genes in COVID-19.多态性影响新冠病毒病中Fas和FasL基因的表达。
Int J Mol Sci. 2025 Jan 14;26(2):666. doi: 10.3390/ijms26020666.
3
Clinical profiles and mortality predictors of hospitalized patients with COVID-19 in Ethiopia.
在埃塞俄比亚住院的 COVID-19 患者的临床特征和死亡预测因素。
BMC Infect Dis. 2024 Sep 2;24(1):908. doi: 10.1186/s12879-024-09836-6.
4
Dysregulated Inflammatory Cytokine Levels May Be Useful Markers in a Better Up-Dated Management of COVID-19.炎症细胞因子水平失调可能是优化新型冠状病毒肺炎(COVID-19)最新管理的有用标志物。
Curr Issues Mol Biol. 2024 Aug 15;46(8):8890-8902. doi: 10.3390/cimb46080525.
5
Severe COVID-19 and long COVID are associated with high expression of STING, cGAS and IFN-α.严重 COVID-19 和长新冠与 STING、cGAS 和 IFN-α 的高表达有关。
Sci Rep. 2024 Feb 29;14(1):4974. doi: 10.1038/s41598-024-55696-0.
6
Predictors of mortality among inpatients in COVID-19 treatment centers in the city of Butembo, North Kivu, Democratic Republic of Congo.刚果民主共和国北基伍省布滕博市新冠病毒治疗中心住院患者的死亡预测因素
PLOS Glob Public Health. 2024 Jan 24;4(1):e0002020. doi: 10.1371/journal.pgph.0002020. eCollection 2024.
7
Demographic characteristics, clinical presentation and in-hospital outcome among patients with Covid-19 in a Nigerian tertiary hospital.尼日利亚一家三级医院的新冠病毒患者的人口统计学特征、临床表现和住院结局。
Malawi Med J. 2023 Mar;35(1):43-57. doi: 10.4314/mmj.v35i1.8.
8
Differences in the severity and mortality risk factors for patients hospitalized for COVID-19 pneumonia between the early wave and the very late stage of the pandemic.新冠疫情早期和极晚期因新冠肺炎肺炎住院患者的严重程度及死亡风险因素差异。
Front Med (Lausanne). 2023 Sep 28;10:1238713. doi: 10.3389/fmed.2023.1238713. eCollection 2023.
9
Statin Use in Relation to COVID-19 and Other Respiratory Infections: Muscle and Other Considerations.他汀类药物的使用与新冠病毒病及其他呼吸道感染的关系:肌肉及其他考量因素
J Clin Med. 2023 Jul 13;12(14):4659. doi: 10.3390/jcm12144659.
10
Association between genetic polymorphism, severity, and treatment response among COVID-19 infected Egyptian patients.新型冠状病毒肺炎感染的埃及患者的基因多态性、严重程度与治疗反应之间的关联
Front Pharmacol. 2023 Jun 22;14:1209286. doi: 10.3389/fphar.2023.1209286. eCollection 2023.